Key facts
- · Type: New offering first sale 2026-03-09 · Amount sold: $1.49M · SEC filing
- · Type: New offering first sale 2022-10-21 · Amount sold: $6K · Total offering: $14M · SEC filing
- · Type: New offering first sale 2019-01-31 · Amount sold: $25K · Total offering: $3M · SEC filing
- · Type: New offering first sale 2018-10-23 · Amount sold: $295K · Total offering: $295K · SEC filing
NEW YORK, NEW YORK
Biotechnology
4
$1.81M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-03-16 | New offering first sale 2026-03-09 | $1.49M | — | SEC filing |
| 2022-10-28 | New offering first sale 2022-10-21 | $6K | $14M | SEC filing |
| 2019-02-05 | New offering first sale 2019-01-31 | $25K | $3M | SEC filing |
| 2018-11-28 | New offering first sale 2018-10-23 | $295K | $295K | SEC filing |
Want the whole picture on Akelos, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Akelos, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Akelos, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from Akelos, Inc.'s own filings with the SEC.
Founders and team named in these filings
| Name | Role stated in the filing | Named in |
|---|---|---|
| Steven Fox | Executive Officer, Director | 2026-03-16, 2022-10-28, 2019-02-05, 2018-11-28 |
Names and roles exactly as the filings list them: executive officers, directors and promoters. Nothing here is inferred, and a filing only lists the people it is required to.